Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Danaher Corporation

Danaher Corporation (DAP.DE) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DAP.DE●XETRA
HealthcareMedical - Diagnostics & Research
€192.00
€1.80(0.93%)
German Market is Open · 16:37

Danaher Corporation (DAP.DE)

Meyka AI Score

Z

Key Financials

Market Cap134.5B
P/E Ratio38.11
EPS (TTM)$5.54
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$205.35
3 Months$200.31
1 Year Target$173.61

DAP.DE Stock Analysis & Investment Overview (XETRA)

Our AI-powered analysis of Danaher Corporation (XETRA: DAP.DE) gives investors deep insight into how the stock performs on the XETRA exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Danaher Corporation's XETRA-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DAP.DE on the XETRA shows an RSI of 58.27, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $173.61 for the XETRA listing.

Key metrics behind Danaher Corporation's XETRA-traded stock include a P/E ratio of 38.11 and a market capitalization of 134.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DAP.DE on the XETRA.

Price Performance (XETRA: DAP.DE)

1-Day Change
-1.26%
5-Day Change
-2.02%
1-Month Change
5.69%
3-Month Change
10.93%
6-Month Change
15.19%
Year-to-Date (YTD) Change
-2.39%
1-Year Change
5.61%
3-Year Change
-5.27%
5-Year Change
-15.89%
All-Time (Max) Change
99211161.40%

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

600,000 Employees
IPO DateDec 15, 2003
CountryUS
Actively Trading

Frequently Asked Questions